Recce Ltd has released a press release.
RCE Awarded $43.7m AusIndustry Advanced Overseas Finding
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Murdoch Children's R327 Efficacy N.gonorrhoeae in-vivo
- Canadian Patent Granted for RECCE Anti-Infectives
- Subjects Dosed Over 15 mins in UTI/Urosepsis Clinical Trial
- Committee Approves Fast 15-Min Infusion in Ph I/II Urosepsis
- Completes Cohort Dosing UTI/Urosepsis Rapid Infusion Trial
Later from Recce Pharmaceuticals
- RCE Awarded Further $11.17m Advanced Overseas Finding
- Murdoch Children's R327 Efficacy UTI in-vivo
- Positive Ph I/II DFI Efficacy Data to Support Site Expansion
- RCE Establishes Strategic Partnership in South-East Asia
- Safety Committee Approves Expansion of Ph I/II DFI Trial
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals